A highly efficient transgene knock-in technology in clinically relevant cell typesAlexander G. Allen, John A. Zuris, Sean Scott et al.|Nature Biotechnology|2023Cited by 66
Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation ModelKai‐Hsin Chang, Haiyan Jiang, Minerva E. Sanchez et al.|Blood|2018Cited by 9
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDTEugenio Marco, Kai‐Hsin Chang, Patricia Sousa et al.|Molecular Therapy|2025Cited by 3